Amphastar Pharmaceuticals Income Statement (2013-2026) | AMPH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	101.66M	112.20M	120.89M	120.37M	123.47M	120.13M	135.02M	140.02M	145.71M	180.56M	178.10M	171.84M	182.39M	191.21M	186.52M	170.53M	174.41M	191.84M	183.10M	171.17M
Gross Profit (Quarter)	47.38M	51.18M	56.23M	55.83M	63.36M	58.51M	71.17M	73.84M	72.74M	108.40M	96.14M	90.10M	95.17M	101.94M	86.65M	85.25M	86.49M	98.65M	85.67M	70.32M
Operating items
Research & Development (Quarter)	18.12M	10.76M	17.29M	16.22M	22.80M	18.51M	17.24M	19.82M	16.84M	16.66M	20.42M	17.04M	17.65M	21.08M	18.14M	20.10M	20.08M	22.35M	23.31M	26.74M
Wages, Salaries and Other (Quarter)												47.84M	46.34M	48.70M	48.40M	49.31M	48.05M	45.87M	48.55M	50.62M
Selling, General & Administrative (Quarter)	14.56M	10.91M	10.62M	12.47M	9.98M	11.98M	10.63M	13.48M	12.28M	12.65M	13.12M	15.68M	13.29M	14.82M	12.94M	16.00M	13.99M	39.47M	16.47M	18.03M
Other Operating Expenses (Quarter)	4.13M	4.75M	4.08M	5.52M	5.76M	4.78M	5.47M	7.11M	6.72M	6.41M	8.62M	9.37M	9.01M	8.99M	10.42M	11.87M	4.84M	11.51M	10.28M	11.93M
Operating Expenses (Quarter)	36.82M	26.41M	31.98M	34.21M	38.53M	35.28M	33.34M	40.41M	35.84M	35.73M	42.16M	42.09M	39.95M	44.89M	41.50M	47.96M	38.91M	73.33M	50.06M	56.69M
Operating Income (Quarter)	10.56M	24.77M	24.25M	21.61M	24.82M	23.23M	37.83M	33.43M	36.90M	72.68M	53.98M	48.01M	55.22M	57.05M	45.14M	37.29M	42.18M	25.32M	-78.84M	13.63M
EBIT (Quarter)	10.56M	24.77M	24.25M	21.61M	24.82M	23.23M	37.83M	33.43M	36.90M	72.68M	53.98M	48.01M	55.22M	57.05M	45.14M	37.29M	42.18M	25.32M	-78.84M	13.63M
Non-operating items
Interest & Investment Income (Quarter)	0.14M	0.14M	0.16M	0.18M	0.23M	0.33M	0.58M	0.92M	1.03M	1.20M	2.30M	2.56M	3.34M	2.43M	2.29M	2.09M	1.92M	2.25M	2.42M	2.40M
Other Non Operating Income (Quarter)	3.60M	13.26M	2.92M	7.59M	-1.50M	-0.40M	3.38M	-0.39M	-1.52M	3.46M	-5.48M	5.92M	0.30M	-5.09M	2.95M	-2.23M	1.51M	0.23M	0.52M	0.57M
Non Operating Income (Quarter)	3.60M	12.88M	2.91M	7.42M	-1.50M	-0.40M	2.85M	0.14M	-4.09M	-9.04M	-27.18M	5.92M	-4.97M	-9.37M	2.95M	-2.23M	1.51M	-3.81M	13.61M	-3.58M
Net income details
EBT (Quarter)	14.22M	37.65M	27.16M	29.03M	23.15M	22.60M	41.26M	33.57M	32.81M	63.64M	41.34M	47.88M	50.24M	47.68M	49.38M	30.86M	39.34M	21.51M	-97.04M	10.05M
Tax Provisions (Quarter)	5.59M	6.69M	7.19M	4.08M	5.55M	6.56M	7.29M	6.75M	6.38M	14.03M	4.67M	4.13M	12.29M	7.25M	6.00M	5.58M	8.30M	4.16M	7.49M	3.63M
Profit After Tax (Quarter)	7.77M	30.96M	19.76M	24.25M	17.35M	15.87M	33.91M	26.03M	26.12M	49.22M	36.17M	43.18M	37.95M	40.43M	37.96M	25.29M	31.03M	17.35M	24.43M	6.42M
Equity Income (Quarter)				-0.70M	-0.25M	-0.16M	-0.06M	-0.79M	-0.30M	-0.39M	-0.51M	-0.57M
Income from Non-Controlling Interests (Quarter)	-0.85M	1.41M	-2.37M
Income from Continuing Operations (Quarter)	8.62M	30.96M	19.97M	24.96M	17.60M	16.04M	33.97M	26.82M	26.43M	49.61M	36.67M	43.75M	37.95M	40.43M	43.38M	25.29M	31.03M	17.35M	-104.52M	6.42M
Consolidated Net Income (Quarter)	8.62M	30.96M	19.97M	24.96M	17.60M	16.04M	33.97M	26.82M	26.43M	49.61M	36.67M	43.75M	37.95M	40.43M	43.38M	25.29M	31.03M	17.35M	-104.52M	6.42M
Income towards Parent Company (Quarter)	8.62M	30.96M	19.97M	24.96M	17.60M	16.04M	33.97M	26.82M	26.43M	49.61M	36.67M	43.75M	37.95M	40.43M	43.38M	25.29M	31.03M	17.35M	-104.52M	6.42M
Net Income towards Common Stockholders (Quarter)	8.62M	30.96M	19.97M	24.96M	17.60M	16.04M	33.97M	26.82M	26.43M	49.61M	36.67M	43.75M	37.95M	40.43M	43.38M	25.29M	31.03M	17.35M	-104.52M	6.42M
Additional items
EPS (Basic) (Quarter)	0.16	0.62	0.41	0.50	0.35	0.32	0.70	0.54	0.54	1.01	0.75	0.90	0.77	0.83	0.79	0.53	0.66	0.38	0.53	0.14
EPS (Weighted Average and Diluted) (Quarter)	0.16	0.59	0.40	0.47	0.33	0.30	0.65	0.50	0.49	0.91	0.69	0.81	0.73	0.78	0.74	0.51	0.64	0.37	0.51	0.14
Shares Outstanding (Weighted Average) (Quarter)	47.63M	47.76M	47.78M	48.14M	48.50M	48.90M	48.55M	48.00M	48.20M	48.70M	48.27M	48.21M	48.56M	48.62M	48.43M	47.64M	47.30M	46.47M	46.74M	45.32M
Shares Outstanding (Diluted Average) (Quarter)
EBITDA (Quarter)	10.56M	24.77M	24.25M	21.61M	24.82M	23.23M	37.83M	33.43M	36.90M	72.68M	53.98M	48.01M	55.22M	57.05M	45.14M	37.29M	42.18M	25.32M	-78.84M	13.63M
Interest Expenses (Quarter)	0.09M	0.53M	0.17M	0.35M	0.40M	0.57M	0.53M	0.40M	3.60M	13.70M	9.46M	8.61M	8.61M	6.70M	6.42M	6.29M	6.28M	6.28M	6.63M	6.55M
Shares Outstanding (Quarter)	-7.75M	56.05M	56.44M	57.50M	57.90M	57.99M	58.11M	58.44M	59.07M	59.22M	59.39M	60.16M	60.48M	60.69M	60.85M	61.29M	61.65M	46.35M	45.65M	62.13M
Tax Rate (Quarter)	39.35	17.76	26.49	14.04	23.98	29.03	17.67	20.11	19.46	22.04	11.30	8.62	24.47	15.21	12.15	18.07	21.11	19.35	-7.71	36.13

Research Tools

Amphastar Pharmaceuticals Income Statement (2013-2026) | AMPH

Create an account

Sign In

Reset Password